U.S. FDA Seizes 33 Products From India's Sun-owned Caraco Detroit Site
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - U.S. FDA toughened its stand on generic drug maker Caraco, ordering it to immediately stop distributing its drugs until the agency had assurance that the firm had complied with its good manufacturing practices